Coronary Restenosis after Drug-Eluting Stent Implantation in Diabetic Patients
Coronary Restenosis after Drug-Eluting Stent Implantation in Diabetic Patients
- 주제(키워드) Diabetes；Coronary restenosis.
- 발행기관 대한심장학회
- 발행년도 2006
- 총서유형 Journal
- UCI G704-000708.2006.36.1.003
- KCI ID ART000986256
초록/요약
In the era of drug-eluting stents (DESs), the angiographic rates of restenosis at later months have been dramaticallyreduced, but these rates have been less prominently reduced in diabetic patients. The rate of coronaryrestenosis is still higher in diabetic patients, when compared with non-diabetic patients, and even after DESimplantation. Diabetes remains a significant predictor of coronary restenosis even in the era of DES, and especiallyin cases having a small baseline vessel size, a small post-PCI vessel size and a longer stent length. The use ofthe sirolimus-eluting stent in diabetic patients has been associated with a decreased rate of restenosis, and thissuggests a reduced risk of target lesion revascularization. Diabetes still remains a major risk factor for coronaryrestenosis after DES implantation, and so aggressive risk factor management with the concomitant pharmacotherapyshould be done to reduce the risk of coronary restenosis. (Korean Circulation J 2006;36:1-7)
more